EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 340 filers reported holding EXELIXIS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,506,124 | -42.7% | 111,532 | -39.5% | 0.01% | -15.4% |
| Q1 2024 | $4,372,941 | -1.1% | 184,279 | 0.0% | 0.01% | -13.3% |
| Q4 2023 | $4,420,853 | +19.2% | 184,279 | +8.6% | 0.02% | +15.4% |
| Q3 2023 | $3,709,300 | +8.8% | 169,762 | -4.8% | 0.01% | +8.3% |
| Q2 2023 | $3,409,472 | -11.6% | 178,413 | -10.2% | 0.01% | -14.3% |
| Q1 2023 | $3,856,088 | +21.0% | 198,665 | 0.0% | 0.01% | +16.7% |
| Q4 2022 | $3,186,587 | +2.3% | 198,665 | 0.0% | 0.01% | -7.7% |
| Q3 2022 | $3,115,000 | -24.7% | 198,665 | 0.0% | 0.01% | -18.8% |
| Q2 2022 | $4,136,000 | -8.2% | 198,665 | 0.0% | 0.02% | +14.3% |
| Q1 2022 | $4,504,000 | +24.0% | 198,665 | 0.0% | 0.01% | +27.3% |
| Q4 2021 | $3,632,000 | -15.0% | 198,665 | -1.7% | 0.01% | -15.4% |
| Q3 2021 | $4,271,000 | +23.8% | 202,023 | +6.7% | 0.01% | +18.2% |
| Q2 2021 | $3,449,000 | -23.5% | 189,300 | -5.2% | 0.01% | -31.2% |
| Q1 2021 | $4,510,000 | +8.3% | 199,653 | -3.8% | 0.02% | +6.7% |
| Q4 2020 | $4,165,000 | -22.4% | 207,539 | -5.4% | 0.02% | -28.6% |
| Q3 2020 | $5,364,000 | +2.0% | 219,389 | -1.0% | 0.02% | -4.5% |
| Q2 2020 | $5,261,000 | +32.7% | 221,617 | -3.8% | 0.02% | +15.8% |
| Q1 2020 | $3,965,000 | -2.3% | 230,259 | 0.0% | 0.02% | +26.7% |
| Q4 2019 | $4,057,000 | -2.9% | 230,259 | -2.6% | 0.02% | -6.2% |
| Q3 2019 | $4,179,000 | – | 236,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |